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Abstract
The aim of this study was to examine the relation between chronotype and breast cancer risk. We 
analyzed the association between chronotype (definite morning type, probable morning type, 
probable evening type, definite evening type, or neither morning nor evening type) and breast 
cancer risk among 72 517 women in the Nurses’ Health Study II (NHS II). Chronotype was self-
reported in 2009, and 1834 breast cancer cases were confirmed among participants between 1989–
2007; a 2-year lag period was imposed to account for possible circadian disruptions related to 
breast cancer diagnosis. Age- and multivariable-adjusted logistic regression was used to estimate 
odds ratios (ORs) and 95% confidence intervals (CIs). Participants who self-reported as neither 
morning nor evening chronotype had a 27% increased risk of breast cancer (multivariable-adjusted 
OR= 1.27; 95% CI, 1.04–1.56), compared to definite morning types. None of the other 
chronotypes were significantly associated with breast cancer risk (multivariable-adjusted OR= .99, 
95% CI, .87–1.12 for probable morning vs. definite morning types, OR=.96, 95% CI, .84–1.09 for 
probable evening vs. definite morning types, and OR=1.15, 95% CI, .98–1.34 for definite evening 
vs. definite morning types). Overall, chronotype was not associated with breast cancer risk in our 
study. A modestly increased risk among neither morning nor evening chronotypes may indicate 
circadian disruption as a potentially underlying mechanism; however, more studies are needed to 
confirm our results.
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Circadian rhythms are regulated by a master clock located within the suprachiasmatic nuclei 
(SCN) of the brain (Fu & Lee, 2003). This clock generates rhythms with an approximate 24-
hour oscillation pattern, is entrained by the light/dark cycle, and is generated by a set of core 
clock genes (Savvidis & Koutsilieris, 2012). The circadian system produces rhythms in 
metabolic, physiological and behavioral functions, including hormone production, sleep-
wake behavior, digestive secretion, and immune response (Fu & Lee, 2003; Savvidis & 
Koutsilieris, 2012). An individual’s circadian rhythms and susceptibility to circadian 
disruption may be influenced by chronotype, which refers to an individual’s preference for 
behavioral timing, particularly the timing of sleep and waking. Chronotype may affect 
adaptability and tolerance to rotating shift work, and thereby may increase the risk of 
adverse health outcomes.
Growing evidence suggests that circadian disruption may lead to an increased risk of breast 
cancer. Multiple studies, including two prospective analyses from within the Nurses’ Health 
Study cohorts, have found rotating night-shift work - a prime disruptor of circadian rhythms-
to be associated with elevated breast cancer risk (Hansen & Lassen, 2012; Pukkala et al., 
1995; Rafnsson et al., 2001; Schernhammer et al., 2006; Schernhammer et al., 2001; Tynes 
et al., 1996). While the underlying mechanisms linking night shift work and increased breast 
cancer risk remain unclear, suppression of the hormone melatonin by light exposure at night, 
insufficient sleep, lifestyle factors, and/or a general disruption of circadian synchrony have 
been suggested (Fritschi et al., 2011).
Whether chronotype influences breast cancer risk and whether this association is modified 
by rotating night shift work status are key questions of interest. To date, one study has 
examined the association between chronotype and breast cancer risk. Results from this study 
suggested that individuals with evening chronotype or neither chronotype had a greater risk 
of breast cancer compared to those with morning chronotype (Hansen & Lassen, 2012). The 
biological mechanism(s) that may underlie such an association are unclear. Core circadian 
clock genes have been shown to act as tumor suppressors or oncogenes, suggesting that 
variations in their expression may be involved in initiation and/or progression of cancer 
growth (Hoffman et al., 2008; Lee, 2006; Saha & Sassone-Corsi, 2007; Yang et al., 2009; 
Savvidis & Koutsilieris, 2012). In fact, several clock genes have been linked to breast cancer 
risk (Hoffman et al., 2010; Zhu et al., 2005; Zhu et al., 2008) and there are also reports that 
SNPs in clock genes are associated with chronotype (Archer et al., 2003; Carpen et al., 
2006; Katzenberg et al., 1998).
Exposure to light at night is a mechanism that has been hypothesized to increase breast 
cancer risk among shift workers by suppressing melatonin secretion (Fritschi et al., 2011). 
Melatonin has been reported to have anti-cancer effects in vitro, and decreased levels of 
melatonin synthesis appear to influence the initiation, promotion, and progression of 
hormone related cancers such as breast cancer (Blask, 2009). Whether light exposure at 
night or suppression of melatonin by light at night differ between chronotypes remains 
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unknown, although the timing of melatonin secretion in non-night shift workers has been 
demonstrated to be significantly different between chronotypes (Duffy et al., 1999).
Given the finding that night shift work increases breast cancer risk (Pukkala et al., 1995; 
Rafnsson et al., 2001; Schernhammer et al., 2006; Schernhammer et al., 2001; Tynes et al., 
1996), the evidence that morning chronotypes are less tolerant of night shift work (Saksvik 
et al., 2011; Gamble et al., 2011; Smith et al., 2005; Saksvik-Lehouillier et al., 2012), and 
the recent report of an association between chronotype and breast cancer risk (Hansen & 
Lassen, 2012), whether chronotype influences breast cancer risk after accounting for a 
history of night-shift work remains unclear. To address these issues, we examined the 
association between chronotype and breast cancer risk among 72 517 women in the Nurses’ 
Health Study II.
MATERIALS AND METHODS
The Nurses’ Health Study II is an ongoing prospective cohort comprised of 116 434 female 
registered nurses, aged 25 to 42 years and living in 14 U.S. states at baseline. Cohort 
members completed a baseline questionnaire in 1989 and subsequent questionnaires have 
been mailed every two years to obtain updated information on lifestyle factors, medical 
history, and newly diagnosed disease. Initial participation and follow-up rates have been 
approximately 90% (Schernhammer et al., 2011).
Assessment of chronotype
In 2009, participants were asked about their chronotype with the question, “One hears about 
morning and evening types of people. Which ONE of these types do you consider yourself 
to be?”. Response categories were given as “definitely a morning type”, “more of a morning 
than an evening type”, “more of an evening than a morning type”, “definitely an evening 
type”, and “neither” (in that order). Chronotype has typically been assessed with 
questionnaires comprised of a series of questions, such as the Horne-Osteberg morningness-
eveningness questionnaire (MEQ) (Horne & Ostberg, 1976). This is a validated 
questionnaire consisting of 19 questions about preferred times to do different types of 
activities during the day, and its scoring follows a Likert-type response format. The answers 
to the 19 questions are summed to determine chronotype in one of 5 categories although the 
response to item 19 (upon which our question was based) has been to shown to be correlated 
with overall chronotype determined from all 19 questions (Roenneberg et al., 2007).
Assessment of rotating night shift work
Detailed information on total years during which the nurse had worked on rotating night 
shifts was available from the 1989 questionnaire, with an update in 1991, 1993, 1997, 2001, 
2005, and 2009. The 1991 and 1993 questionnaire collected information about total number 
of months during which the nurse had worked rotating night shifts with at least 3 nights per 
month in addition to days or evenings in that month (since June 1989 and 1991, 
respectively). Pre-specified categories on total numbers of months working on rotating night 
shifts were “none, 1–4 months, 5–9, 10–14, 15–19, and 20 months or more.” In addition, in 
2001, gaps were filled by asking for number of months worked on rotating night shifts 
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between 1995 and 1997, as well as 1997 and 1999. Specifically, nurses were asked “During 
the following time periods, how many months have you worked rotating night shifts (at least 
3 nights per month in addition to other days and evenings in that month)?”.
Documentation of breast cancer cases and death
Study participants were asked if they had been previously diagnosed with breast cancer in 
the initial questionnaire in 1989, and they were asked in each follow-up questionnaire, from 
1991 to 2009, if they had been diagnosed with breast cancer within the past two years. If 
newly diagnosed breast cancer was reported, permission to access medical records was 
obtained and diagnosis was confirmed by the participant’s doctor, medical records, or 
pathology reports. Breast cancer was additionally reported during death follow-up when 
family members, postal service, or the National Death Index informed the study that a 
participant was deceased. After each follow-up cycle, the National Death Index was also 
reviewed for study participants who were unresponsive, and if death was confirmed the 
death certificate was used to identify the cause of death.
Population for analysis
In total, 90 480 women completed the NHS II questionnaire in 2009. Of these, we excluded 
665 cases of breast cancer in situ, and 4783 cases of other cancer (except for non-melanoma 
skin cancer), occurring between baseline in 1989 and 2007. In addition, 12 515 women were 
excluded because they did not answer the chronotype question (i.e., an 85% response rate 
among women who answered the 2009 questionnaire). Thus, the base population for this 
analysis was comprised of 72 517 women from NHS II. Participants who provided 
chronotype information generally were similar to those who did not provide chronotype 
information (mean age=52.9 vs. 52.7 years, mean body mass index for both groups=27.5 
kg/m2).
Statistical analysis
We used multivariable-adjusted logistic regression models to estimate odds ratios (OR) and 
95% confidence intervals (CI) of breast cancer across five categories of chronotype (definite 
morning type, probable morning type, probable evening type, definite evening type, and 
neither morning nor evening type). Definite morning type was used as the referent group 
because it represented the largest group of women in our study and we assumed that this 
group would experience the least circadian disruption. We imposed a 2-year lag period to 
ensure that breast cancer cases occurred at least 2 years prior to chronotype reporting, 
because we were concerned that factors related to diagnosis (e.g., treatment effects) might 
alter a woman’s perception of her usual chronotype. We calculated age-adjusted estimates, 
and additionally adjusted for the following potential confounding factors: family history of 
breast cancer (yes, no), age at menarche (<12,12,13, ≥14), history of rotating night-shift 
work in years (never, 1–9, ≥10 years), smoking status (never smoker/past smoker, current 
smoker <25 cigarettes per day, current smoker ≥25 cigarettes per day), body mass index 
(BMI) in kg/m2 (<18.5, 18.5–19.9, 20.0–22.4. 22.5–24.9, 25.0–29.9, ≥30 kg/m2), alcohol 
intake in g/day (non-drinkers, <5, 5–9.9, 10–19.9, and ≥20 g/day), physical activity in MET-
hours/week (quintiles), history of benign breast disease (yes, no), oral contraceptive use 
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(never, ever), menopausal status (premenopausal, postmenopausal), age at menopause in 
years (<48, 48, 49, ≥50), parity and age at first birth (nulliparous; age at first birth <25, 1–2 
children; age at first birth 25–29, 1–2 children; age at first birth ≥30, 1–2 children; age at 
first birth <25, ≥3 children; age at first birth ≥25, ≥3 children), and postmenopausal hormone 
use (never, ever). All covariates were determined in 2007.
We conducted several secondary analyses. First, we stratified by history of rotating night-
shift work status (never, 1–9, ≥10 years) to evaluate whether the association between 
chronotype and breast cancer risk was similar among women with different histories of 
rotating night-shift work. Second, we examined whether the association between chronotype 
and the risk of breast cancer was stronger among women with body mass index ≥25 kg/m2 
compared to women with body mass index <25 kg/m2, as previous studies have indicated 
that individuals with evening chronotype have an increased risk of obesity. Likelihood ratio 
tests were used to test for interaction in both of these analyses.
All p-values were based on two-sided tests and were considered statistically significant if p 
< .05. We used SAS software, version 9 (SAS Institute Inc., Cary, North Carolina, U.S.) for 
all statistical analyses.
RESULTS
We documented a total of 1834 prevalent cases of invasive breast cancer between 1989 and 
2007. The chronotype distribution in this sample was as follows: 34% definite morning 
types, 26% probable morning types, 23% probable evening types, 12% definite evening 
types, and 5% neither morning nor evening types. Overall, the individuals in the chronotype 
groups were fairly similar in terms of their age and age-standardized characteristics (shown 
in Table 1). Definite evening types were more likely to be obese and smoke, consumed less 
alcohol, and had lower physical activity levels compared to morning types. Probable 
evening types were also less physically active than morning types. Moreover, definite 
evening and neither types appeared to be more likely to engage in long term rotating night 
shift work, compared to morning types.
Table 2 shows age-adjusted and multivariable-adjusted associations between chronotype and 
breast cancer risk; we present multivariable-adjusted results only because results were very 
similar to the unadjusted results. In multivariable models, adjusting for a variety of possible 
confounding factors, probable morning and probable evening chronotypes were not 
associated with breast cancer risk (OR=.99, 95% CI .87–1.12 for probable morning vs. 
definite morning types, and OR=.96, 95% CI .84–1.09 for probable evening vs. definite 
morning types). Women who reported being neither morning nor evening chronotype had a 
27% increased risk of breast cancer, compared to women with definite morning chronotype 
(multivariable-adjusted OR=1.27, 95% CI 1.04–1.56). In addition, definite evening 
chronotype was related to a 15% increased risk of breast cancer (multivariable-adjusted 
OR=1.15, 95% CI .98–1.34), but was not statistically significant. Results did not differ 
according to estrogen receptor status of the breast tumors (data not shown).
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We found no evidence that the association between chronotype and breast cancer risk 
differed according to history of night-shift work (LRT statistic=1.07 < χ21 df=3.84, therefore 
p>.05). Among women without a history of rotating night shift work, those who were 
neither morning nor evening chronotype had a 46% increased risk of breast cancer compared 
to definite morning types (number of cases=534; multivariate-adjusted OR=1.46, 95% CI 
1.01–2.12); among women with neither chronotype who had 1–9 years of shift work history, 
the relative risk of breast cancer was increased by 26% above definite morning types 
(number of cases=1119; multivariable-adjusted OR=1.26, 95% CI=.97–1.64), and among 
women with neither chronotype and ≥10 years of shift work history, breast cancer risk 
decreased by 8% when compared to women with definite morning type (number of 
cases=170; multivariable-adjusted OR=.92, 95% CI=.45, 1.86). When we stratified analyses 
by BMI category, the association between women with neither chronotype and breast cancer 
risk was somewhat stronger among women with a body mass index ≥ 25 kg/m2 (number of 
cases=999; multivariable-adjusted OR=1.40, 95% CI 1.07–1.83 comparing neither vs. 
definite morning types) than among women with a body mass index <25 kg/m2 (number of 
cases=738; multivariable-adjusted OR=1.13, 95% CI .81–1.58 comparing neither vs. 
definite morning types). However, the interaction term was not significant in multivariable-
adjusted models (LRT statistic=.19 < χ21 df=3.84, therefore p>.05).
DISCUSSION
In this study, we observed an elevated risk of breast cancer among women with neither 
morning nor evening chronotypes, compared to definite morning chronotypes, after 
adjustment for possible confounders. Although there was a marginally increased risk of 
breast cancer in definite evening types compared to definite morning types, this association 
was not significant. Results were similar when analyses were restricted to participants 
without a history of shift work.
A recent nested case-control study of cumulative shift work on breast cancer risk included 
an analysis by self-reported chronotype (morning, evening, and neither/mixed preference) 
among a cohort of 18 551 women in the Danish military (Hansen & Lassen, 2012). The 
authors reported an increased breast cancer risk among women who worked night shifts and 
had an evening preference compared to those with morning preference (OR =1.8; 95% CI 
1.2 – 2.9) as well as those with mixed/neither preference compared to those with morning 
preference (OR =1.6; 95% CI 1.0–2.7). Even though the Danish cohort differed from ours in 
terms of how chronotype was assessed, we too, observed an increased risk of breast cancer 
among the neither chronotype group in our analysis and a marginally increased risk 
(although not statistically significant) of breast cancer among definite evening types.
Despite the lack of a significant association between evening chronotype and breast cancer 
risk in our analysis, the increased risk among neither chronotype is intriguing. One possible 
explanation is that our findings are due to chance given the small number of neither 
chronotypes in our sample. Further, the neither types could represent individuals who 
misclassified themselves due to misunderstanding the chronotype question (Randler & 
Vollmer, 2012). Alternatively, our results may indicate that the neither types (just like the 
mixed/neither types in the Danish study) may have less regulated circadian rhythms, leading 
Ramin et al. Page 6













to a higher risk for circadian disruption. Recently, the possibility of an additional chronotype 
that represents a bimodal circadian pattern has been suggested (Randler & Vollmer, 2012; 
Martynhak et al., 2010). Bimodal chronotypes are described as having traits that are 
consistent with both morning and evening types, hypothesized to be due to a dual morning 
and evening oscillator (Martynhak et al., 2010). When taking Likert-type surveys to assess 
morningness-eveningness, bimodal chronotypes will answer some questions with a morning 
type response and other questions with an evening type response. This results in their overall 
responses being summed up as a neither type score even though their individual responses to 
the questions do not fall in the middle between morning and evening type responses, as do 
those of more typical neither types (Randler & Vollmer, 2012). It is possible that neither 
chronotypes in our analysis may be bimodal types, and we hypothesize that such individuals 
may be at higher risk for breast cancer due to their bimodal circadian rhythms, which may 
increase susceptibility to circadian disruption. However, this hypothesized link between 
bimodal circadian rhythms and circadian disruption has not been demonstrated. Nonetheless, 
our findings, together with those from the study of Hansen & Lassen (2012), warrant further 
investigation of the association between neither chronotype and breast cancer risk, and better 
understanding of bimodal chronotypes.
There are several limitations to our analysis. First, the assessment of chronotype was self-
reported after the occurrence of breast cancer, and hence was collected retrospectively. 
Chronotype has been documented to change towards morningness as age increases (Taillard 
et al., 2004), thus it is possible that women who were evening/neither types at the time of 
breast cancer incidence might have rated themselves as morning types on the subsequent 
chronotype assessment in 2009. As a result, associations may be harder to detect with 
evening/neither types and may have biased our result toward the null. In addition, 
chronotype was measured with one question instead of a series of questions, such as the 
Horne and Ostberg morningness-eveningess questionnaire (MEQ) (Horne & Ostberg, 1976). 
Although it is somewhat difficult to determine how this might have influenced our findings, 
results from a one-question assessment such as we used have been shown to correlate well 
with chronotype classifications derived from a more detailed questionnaire (Roenneberg et 
al., 2007). Second, this is an observational study and therefore we cannot rule out the 
possibility of residual confounding. However, we accounted for well-established breast 
cancer risk factors and adjustment for these risk factors did not substantially change our 
estimates. Third, the Nurses’ Health Study II is a cohort of health professionals with a high 
percentage of rotating and night shift workers, which could limit the generalizability of our 
findings. However, when we excluded night shift workers from our analysis, this did not 
change the association between chronotype and breast cancer risk. Lastly, despite the long 
survival after breast cancer diagnosis, there were 158 women with a breast cancer diagnosis 
who died prior to chronotype assessment in 2009. To ensure that the inclusion of prevalent 
cases still alive in 2009 did not bias our estimates (i.e., women had to be alive in 2009 to 
answer the chronotype question and be included in our study), we compared the tumor 
histopathology of cases in our analyses vs. cases that were excluded because they did not 
have information on chronotype. The breast tumors of cases in our study were largely 
comparable to tumors of women who had died prior to 2009, although they tended to be 
slightly better differentiated and a larger proportion of them were ER positive. However, the 
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association between chronotype and breast cancer was not different among women with ER 
positive vs. negative or more vs. less differentiated tumors in our sample. Nonetheless, 
although it appears unlikely that chronotype is associated with breast cancer survival, we 
cannot entirely rule out the possibility that the association between chronotype and breast 
cancer risk was different among women who died prior to chronotype assessment. Finally, 
recall bias appears unlikely in our prevalent cases because, to our knowledge, the public 
does not perceive chronotype as carcinogenic.
In conclusion, we observed an increased risk of breast cancer among women with self-
reported chronotypes that were neither morning nor evening types. There is a lack of 
research on neither chronotypes, and further research is warranted to understand this 
population and the underlying mechanisms that may be driving the increased risk of breast 
cancer.
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